SAMSUNG PHARM. Co., LTD. Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2018	FY 2017	FY 2016
Period Ending	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Net Income	-2,076	-7,540	-21,618
Depreciation & Amortization	3,764	3,915	4,267
Loss (Gain) From Sale of Assets	-	-292.49	-35.19
Asset Writedown & Restructuring Costs	-	577.53	4,342
Loss (Gain) From Sale of Investments	-1,912	4,878	2,330
Provision & Write-off of Bad Debts	-134.69	-1,329	-2,427
Other Operating Activities	664.44	-19.83	5,641
Change in Accounts Receivable	-1,115	461.78	957.68
Change in Inventory	802.18	1,192	-5,931
Change in Accounts Payable	-1,536	2,458	1,564
Change in Other Net Operating Assets	-4,978	850.75	968.02
Operating Cash Flow	-6,521	5,152	-9,941
Capital Expenditures	-2,614	-6,108	-33,236
Sale of Property, Plant & Equipment	8,167	330.8	75.03
Cash Acquisitions	-	-4,000	-
Sale (Purchase) of Intangibles	-1,079	-278.61	-1,106
Investment in Securities	-1,347	400	8,538
Other Investing Activities	-976.48	752.26	-599.29
Investing Cash Flow	-6,598	-22,259	-28,343
Short-Term Debt Issued	-	11,280	-
Long-Term Debt Issued	-	11,250	5,650
Total Debt Issued	-	22,530	5,650
Short-Term Debt Repaid	-17,886	-	-1,734
Long-Term Debt Repaid	-8.4	-3,116	-20,643
Total Debt Repaid	-17,894	-3,116	-22,377
Net Debt Issued (Repaid)	-17,894	19,414	-16,727
Issuance of Common Stock	31,233	-	40,810
Financing Cash Flow	13,339	19,414	24,083
Miscellaneous Cash Flow Adjustments	-	-4,766	-0
Net Cash Flow	219.74	-2,459	-14,202
Free Cash Flow	-9,134	-956.01	-43,177
Free Cash Flow Margin	-19.65%	-2.28%	-91.49%
Free Cash Flow Per Share	-178.27	-23.96	-1318.23
Cash Interest Paid	1,421	915.61	1,234
Cash Income Tax Paid	11.67	88.93	338.17
Levered Free Cash Flow	-16,402	-4,883	-41,611
Unlevered Free Cash Flow	-15,554	-3,264	-40,076
Change in Working Capital	-6,827	4,963	-2,442

Updated Nov 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.